Clinical Trial Update: HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial investigating HP Xenon-129 fMRI in healthy volunteers and participants with Alzheimer's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Thunder Bay Regional Health Research Institute | Conditions: Alzheimer Disease | EARLY_Phase 1 | Status: TERMINATED